发明名称 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
摘要 The present invention involves the use of transcription factors including Tbx5, Mef2C, Hand2, myocardin and Gata4 to reprogram cardiac fibroblasts into cardiomyocytes, both in vitro and in vivo. Such methods find particular use in the treatment of patients post-myocardial infarction to prevent or limit scarring and to promote myocardial repair.
申请公布号 US9017661(B2) 申请公布日期 2015.04.28
申请号 US201213402609 申请日期 2012.02.22
申请人 The Board of Regents of the University of Texas System 发明人 Nam Young-Jae;Song Kunhua;Olson Eric N.
分类号 A61K48/00;C12N15/85;C12N5/071;A61K35/24;A61P9/10;C07K14/47;C12N5/077;A61K38/00 主分类号 A61K48/00
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A method of treating a subject having suffered a myocardial infarct (MI) comprising delivering to the heart of said subject Tbx5, Gata4, Hand2 and Mef2C expression cassettes.
地址 Austin TX US